Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

 

MC Services sponsors Best Technology Award at the 2017 European Mediscience Awards


MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.


Nominations for the 2017 Mediscience Awards are open – it’s time to get voting!


Learn more

 

 

Newron Pharmaceuticals and MorphoSys @ LaBiotech Refresh Afterwork Meetup


On April 3rd LaBiotech is hosting the first Meeting of its newly launched monthly Refresh Afterwork Meetup Series. This time, fireside chats will feature Stefan Weber, CEO of Newron Pharmaceuticals, and Simon Moroney, CEO and co-founder of Morphosys.

 

When:  April 3rd

Where:  Munich, IZB Residence CAMPUS AT HOME

Programme:

18:30 - 19:00: Welcoming

19:00 - 19:30: 1st Fireside Chat – Stefan Weber, CEO - Newron

19:30 - 20:00: 2nd Fireside Chat – Simon Moroney, CEO & Co-founder – Morphosys

20:00 - 21:00: Enjoy beers from Munich and networking

 

Free Entry


Learn more

MorphoSys's CSO Marlies Sproll Takes Temporary Leave Markus Enzelberger to Serve as Interim CSO (news with additional features)

www.morphosys.de

Medigene AG: Medigene revises collaboration with Mitsui Norin

www.medigene.de

Medigene AG: Announces target and outlines design for its first clinical trial in TCR cancer immunotherapy
(MDG1011)

www.medigene.de

Medigene AG: Medigene publishes its 2016 annual report and outlook for 2017

www.medigene.com

Probiodrug AG to Publish its Full Year 2016 Results on 30 March 2017 

www.probiodrug.de

2016 annual results

www.carbios.fr

SYGNIS anounces change in guarantee for Spanish government soft loans

www.sygnis.com

FDA approves Xadago® (safinamide) for Parkinson’s disease (PD) patients

www.newron.com

RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn's Disease

www.redhillbio.com

Notice of Preliminary Results

www.ergomedplc.com

4SC-202 – a promising combination partner for cancer treatmen

www.4sc.com